Why is Sunil Healthcare falling/rising?

As of 27-Oct, Sunil Healthcare Ltd is currently priced at 72.00, reflecting an increase of 0.7 or 0.98%. Today's performance indicates that the stock has outperformed its sector by 1.1%. However, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a downward trend in the stock's price over a longer period. Additionally, there has been a significant decline in investor participation, with delivery volume dropping by 85.66% compared to the 5-day average. Despite a negative return of -14.08% over the past year, the company has shown a remarkable profit increase of 109.8%, which may indicate potential for recovery. However, the stock's long-term fundamental strength is weak, as evidenced by a low average Return on Capital Employed (ROCE) of 5.38% and a high Debt to EBITDA ratio of 6.67 times.
In the broader market context, Sunil Healthcare's short-term performance has been underwhelming, with a -0.57% return over the past week, while the benchmark Sensex has gained 0.49%. This underperformance is consistent with the stock's longer-term trends, where it has lagged behind the BSE500 in returns over the past three years, one year, and three months. The company's weak long-term growth metrics, including a modest annual growth rate in net sales of 2.85% and operating profit growth of 19.70% over the last five years, further contribute to the negative sentiment surrounding the stock. Overall, while there are some positive indicators, the prevailing trends and fundamental weaknesses suggest a challenging environment for Sunil Healthcare Ltd.